Tuberculosis in the United States National Tuberculosis Surveillance System Highlights from 2011 National Center for HIV/AIDS, Viral Hepatitis, STD, and.

Slides:



Advertisements
Similar presentations
Figure 1. Number of Tuberculosis Cases: California, California Department of Public Health, Tuberculosis Control Branch Number of Tuberculosis.
Advertisements

Development of extensive drug resistance in Multi-Drug resistant tuberculosis patients MSF anti-TB programmes in Abkhazia and Uzbekistan Authors: Cathy.
National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention Epidemiology of HIV Infection through 2012.
Late HIV Diagnoses, Georgia,
World Tuberculosis Day 2015 The TB situation in 2013: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
HIV/AIDS Prevalence & Mortality Report, 2010 Minnesota Department of Health HIV/AIDS Surveillance System Minnesota Department of Health HIV/AIDS Surveillance.
HIV Surveillance – Persons Who Inject Drugs National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention.
HIV Surveillance by Race/Ethnicity National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention.
Module 3: Drug-Resistant TB. Learning Objectives Describe how drug resistance emerges Explain the difference between primary and secondary resistance.
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
Tuberculosis in the UK 2013 report
HIV/AIDS Prevalence & Mortality Report, 2001 Minnesota Department of Health HIV/AIDS Surveillance System Minnesota Department of Health HIV/AIDS Surveillance.
Florida Department of Health HIV/AIDS & Hepatitis Section Annual data trends as of 12/31/2012 Living (Prevalence) data as of 05/16/2012 Epidemiology of.
4 th National Anti-tuberculosis Drug Resistance Survey Botswana, 2007.
Maps Based on Data from 2013 HIV Surveillance Report (through 2013) National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS.
Sexually Transmitted Disease Surveillance 2013 Division of STD Prevention.
Culture Conversion and Self- Administered Therapy in Privately Managed Tuberculosis Patients Melissa Ehman MPH, Jennifer Flood MD MPH, Pennan Barry MD.
Figure 1. Number of Tuberculosis Cases: California, California Department of Public Health, Tuberculosis Control Branch Number of Tuberculosis.
Epidemiology of HIV Among Asians and Pacific Islanders Reported in Florida, Through 2014 Florida Department of Health HIV/AIDS Section Division of Disease.
Impact of HIV Disease, Among the Caribbean-Born, Reported in Florida, Through 2013 Florida Department of Health HIV/AIDS Section Division of Disease Control.
Global and U.S. Tuberculosis Epidemiology and Principles of Control
The Changing Landscape of TB: Maryland TB in 2013 Presented by Dr. David Blythe Lisa Paulos, RN MPH, Epidemiologist Center for TB Control & Prevention.
Epidemiology of HIV Among Hispanics Reported in Florida, Through 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division of Disease Control.
1 Epidemiology of Pediatric Tuberculosis in the United States, 1993–2006 Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis.
Division of Tuberculosis Elimination Centers for Disease Control and Prevention Tuberculosis in the United States National Surveillance System Highlights.
Impact of HIV Disease, Among the Caribbean-Born, Reported in Florida, Through 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division.
Colorado Department of Public Health and Environment Tuberculosis Prevention and Control Program.
Tuberculosis Treatment Completion Among Persons Incarcerated at Diagnosis, U.S. TB Surveillance System, 1999–2008 Kiren Mitruka, MD, MPH (presented on.
Directly Observed Therapy  Prescribed by a physician and required by policy for all public and private patients  Strategy to ensure uninterrupted TB.
Tuberculosis in the 21 st Century Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer.
Division of Tuberculosis Elimination Centers for Disease Control and Prevention Tuberculosis in the United States National Tuberculosis Surveillance System.
2,500 3,000 3,500 4,000 4,500 5,000 5,500 6,000 2,500 3,000 3,500 4,000 4,500 5,000 5,500 6,000 Figure 1. Number of Tuberculosis Cases: California,
Epidemiology of HIV Among Men in Florida, Reported through 2013 Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection.
Epidemiology of HIV Among Men in Florida, Reported through 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division of Disease Control.
HIV Disease and Hepatitis C Virus (HCV) Co-Infection – Florida, 2011 HIV/AIDS & Hepatitis Program - Surveillance Section HIV Disease data from 1981 through.
Healthy People 2010 Focus Area 13: HIV Progress Review August 30, 2007.
Epidemiology of Tuberculosis in African-American Population, United States Kenneth G. Castro, M.D. Assistant Surgeon General, USPHS Director,
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
Epidemiology of Tuberculosis in Correctional Facilities, United States, Surveillance, Epidemiology and Outbreak Investigations Branch Division.
Epidemiology of HIV Among Hispanics Reported in Florida, Through 2013 Florida Department of Health HIV/AIDS Section Division of Disease Control and Health.
Number of Tuberculosis Cases: California, Number of Tuberculosis Cases.
AIDS Cases with TB Florida 2013 TB Created: 12/27/13 Revision: 10/16/14 To protect, promote and improve the health of all people in Florida through integrated.
Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.
Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2014 Living (Prevalence)
California Update : TB Epidemiology and Indicators CTCA October 22, 2010 Jennifer Flood MD MPH Chief, Surveillance and Epidemiology Tuberculosis Control.
Florida Department of Health HIV/AIDS & Hepatitis Program Annual data trends as of 12/31/2011 Living (Prevalence) data as of 05/16/2012 Epidemiology of.
HIV Surveillance in Urban and Nonurban Areas through 2013 National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention.
Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.
Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2013 Living (Prevalence)
HIV Surveillance by Race/Ethnicity
Predictors of Failure in Timely TB Treatment Completion, United States Carla Winston,PhD TB PEN Focal Point Open Forum June 5,
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention.
Figure 1. Number of Tuberculosis Cases: California, Number of Tuberculosis Cases
HIV Care Continuum New Diagnoses, 2011, Georgia. Persons with HIV Engaged in Selected Stages of the Continuum of Care, United States Percent
Epidemiology of HIV Among Men in Florida, Reported through 2011 Florida Department of Health HIV/AIDS & Hepatitis Program Annual data as of 12/31/2011.
AIDS Cases with Tuberculosis – Florida, 2014 TB Created: 09/25/15 Revision: 01/26/16 To protect, promote and improve the health of all people in Florida.
HIV Surveillance in Women National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention.
Epidemiology of HIV Among Asians and Pacific Islanders Reported in Florida, Through 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division.
TB Control Program County of San Diego County of San Diego Health and Human Services Agency Tuberculosis Control Branch Trends in Tuberculosis Highlights.
Impact of HIV Disease, Among the Caribbean-Born, Florida, 2014 Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection.
Tuberculosis in the United States
Tuberculosis in the United States
Tuberculosis in the United States
HIV Surveillance in Adolescents and Young Adults
Reported TB Cases United States, (Log Scale) Cases Year
Tuberculosis in the United States
World Tuberculosis Day 2015
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Tuberculosis in Wales Annual Report 2018 Data to the end of 2017
Tuberculosis in Wales Annual Report 2017 Data to the end of 2016
Presentation transcript:

Tuberculosis in the United States National Tuberculosis Surveillance System Highlights from 2011 National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination

Reported TB Cases United States, 1982–2011* *Updated as of June 25, No. of Cases Year

No.Rate* , , , , , , *Cases per 100,000. Updated as of June 25, TB Morbidity United States, 2006–2011

TB Case Rates,* United States, 2011 *Cases per 100,000. < 3.4 (2011 national average) >3.4 D.C.

TB Case Rates* by Age Group United States, 1993–2011 * Updated as of June 25, Cases per 100,000 Age Group (years)

Reported TB Cases by Age Group, United States, 2011

TB Case Rates by Age Group and Sex, United States, 2011 Cases per 100,000

TB Case Rates by Race/Ethnicity* United States, 2003–2011** *All races are non-Hispanic. **Updated as of June 25, Cases per 100,000

TB Case Rates by Age Group and Race/Ethnicity* United States, 2011 *All races are non-Hispanic. Persons reporting two or more races accounted for less than 1% of all cases. Cases per 100,000

Reported TB Cases by Race/Ethnicity* United States, 2011 *All races are non-Hispanic. Persons reporting two or more races accounted for less than 1% of all cases.

Number of TB Cases in U.S.-born vs. Foreign-born Persons United States, 1993–2011* *Updated as of June 25, No. of Cases

Trends in TB Cases in Foreign-born Persons United States, 1991 – 2011* *Updated as of June 25, No. of CasesPercentage

Reported TB Cases by Origin and Race/Ethnicity,* United States, 2011 *All races are non-Hispanic. Persons reporting two or more races accounted for less than 1% of all cases. ** American Indian or Alaska Native and Native Hawaiian or Other Pacific Islander accounted for less than 1% of foreign-born cases and are not shown. U.S.-born Foreign-born**

>50% 25%–49% <25% DC *Updated as of June 25, Percentage of TB Cases Among Foreign-born Persons, United States* DC

TB Case Rates in U.S.-born vs. Foreign-born Persons, United States, 1993 – 2011* *Updated as of June 25, Cases per 100,000

TB Case Rates in U.S.-born vs. Foreign-born Persons, United States*, 1993 – 2011** *Includes the same data as slide 15, but rates presented on a logarithmic scale. **Updated as of June 25, Cases per 100,000

Countries of Birth of Foreign-born Persons Reported with TB, United States, 2011

Percent of Foreign-born with TB by Time of Residence in U.S. Prior to Diagnosis, 2011 *Foreign-born TB patients for whom information on length of residence in the U.S. prior to diagnosis is unknown or missing

Primary Anti-TB Drug Resistance United States, 1993 – 2011* *Updated as of June 25, Note: Based on initial isolates from persons with no prior history of TB. Multidrug resistant TB (MDR TB) is defined as resistance to at least isoniazid and rifampin % Resistant

Primary MDR TB United States, 1993 – 2011* *Updated as of June 25, Note: Based on initial isolates from persons with no prior history of TB. MDR TB defined as resistance to at least isoniazid and rifampin. No. of CasesPercentage

Primary Isoniazid Resistance in U.S.-born vs. Foreign-born Persons United States, 1993 – 2011* *Updated as of June 25, Note: Based on initial isolates from persons with no prior history of TB. % Resistant

*Updated as of June 25, Note: Based on initial isolates from persons with no prior history of TB. MDR TB defined as resistance to at least isoniazid and rifampin. Primary MDR TB in U.S.-born vs. Foreign-born Persons United States, 1993 – 2011* % Resistant

XDR TB Case Count Defined on Initial DST * by Year, 1993 – 2011** * Drug susceptibility test ** Updated as of June 25, Note: Extensively drug-resistant TB (XDR TB) is defined as resistance to isoniazid and rifampin, plus resistance to any fluoroquinolone and at least one of three injectable second-line anti-TB drugs Case Count Year of Diagnosis

Reporting of HIV Test Results in Persons with TB by Age Group United States, 1993 – 2011* *Updated as of June 25, Note: Includes TB patients with positive, negative, or indeterminate HIV test results. HIV test results not reported from California after HIV test results not reported from Rhode Island for years HIV test results not reported from Vermont after % with Test Results

Estimated HIV Coinfection in Persons Reported with TB, United States, 1993 – 2011* *Updated as of June 25, 2012 Note: Minimum estimates based on reported HIV-positive status among all TB cases in the age group % Coinfection

TB Cases by Residence in Correctional Facilities, Age ≥15, United States, * *Updated as of June 25, 2012 Note: Resident of correctional facility at time of TB diagnosis

TB Cases Reported as Homeless in the 12 Months Prior to Diagnosis, Age ≥15, United States, * *Updated as of June 25, 2012 Note: Homeless within past 12 months of TB diagnosis

Mode of Treatment Administration in Persons Reported with TB United States, 1993 – 2009* *Updated as of June 25, Data available through 2009 only. **Percentage of total cases in persons alive at diagnosis, with an initial regimen of one or more drugs prescribed, and excluding cases with unknown mode of treatment administration. Directly observed therapy (DOT); Self-administered therapy (SA) Percentage**

Completion of TB Therapy United States, 1993 – 2009* * Updated as of June 25, Data available through 2009 only. Note: Includes persons alive at diagnosis, with initial drug regimen of one or more drugs prescribed, who did not die during therapy. Excludes persons with initial isolate rifampin resistant, or patient with meningeal disease, or pediatric patient (aged <15) with miliary disease or positive blood culture. Percentage